Cite
HARVARD Citation
Kalff, A. et al. (2021). Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD). Leukemia & lymphoma. 62 (12), pp. 2981-2991. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kalff, A. et al. (2021). Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD). Leukemia & lymphoma. 62 (12), pp. 2981-2991. [Online].